Published in Hepatitis Weekly, November 7th, 2005
According to recent research published in the Saudi Medical Journal, "bcl-2 is an oncogene that prevents apoptosis (programmed cell death). Expression of bcl-2 protein has been reported in association with a variety of human tumors. This study was conducted in the Department of Gastroenterology and Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey during the period 1996 to 2000 on formalin-fixed paraffin embedded tissue specimens of 69 liver biopsy with chronic liver disease."
"To evaluate the clinical importance of bcl-2 expression in chronic liver disease and its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.